| |
| |
|
| Insider
Information: |
Slonin Jonathan |
| Relationship: |
Chief Medical Officer |
| City: |
Parsippany |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
51,196 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,343,895 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
51,196 |
|
|
| Total
Value |
$1,343,895 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Medical Officer |
2024-01-02 |
51,196 |
2021-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
51,196 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Medical OfficerOfficer |
• – – |
2023-12-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,884 |
|
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2023-06-07 |
4 |
S |
$37.87 |
$18,554 |
D/D |
(490) |
36,323 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2023-06-06 |
4 |
S |
$38.99 |
$18,365 |
D/D |
(471) |
36,813 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2022-08-03 |
4 |
S |
$55.70 |
$17,156 |
D/D |
(308) |
37,079 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2022-07-05 |
4 |
S |
$57.19 |
$52,842 |
D/D |
(924) |
37,387 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,900 |
38,097 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2022-06-06 |
4 |
S |
$61.37 |
$22,217 |
D/D |
(362) |
28,197 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2022-05-23 |
4 |
OE |
$52.37 |
$104,740 |
D/D |
2,000 |
28,559 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Chief Clinical Officer |
• – – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
26,350 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
